Stock data
Ovid Therapeutics Inc. (OVID)
Ovid Therapeutics Inc. (OVID) reported revenue of US$7.25M and net income of -US$17.41M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$7.25M | — | -US$42.44M | -US$17.41M | — |
| 2024 | US$0.57M | — | -US$61.88M | -US$26.43M | — |
| 2023 | US$0.39M | — | -US$59.28M | -US$52.34M | — |
| 2022 | US$1.50M | — | -US$55.55M | -US$54.17M | — |
| 2021 | US$208.38M | — | US$124.21M | US$122.83M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.73M | -US$15.01M | — |
| 2026-03-31 | US$0.00M | -US$16.99M | — |
| 2025-12-31 | US$0.72M | US$9.66M | — |
| 2025-09-30 | US$0.13M | -US$12.16M | — |
| 2025-06-30 | US$6.27M | -US$4.68M | — |
| 2025-03-31 | US$0.13M | -US$10.23M | — |
| 2024-12-31 | US$0.08M | -US$9.25M | — |
| 2024-09-30 | US$0.17M | -US$14.01M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.